Tuesday, January 19, 2021
The Hemp CBD Times. Every minute hemp cbd industry news.

Category: GW Pharmaceuticals


Canopy Growth Corporation patented cannabis extraction infringed, CGC v. GW

Canopy Growth Corporation acquired a patented cannabis extraction technique that GW Pharmaceuticals allegedly infringed. So, two giant players in Canada’s…

By hempcbdtimes , in Business Cannabis Cannabis 101 cannabis extracts Cannabis News Canopy Growth Canopy Growth Corp Canopy Growth Corporation CBD CBD News CBDA Epidiolex Events featured Greenwich biosciences GW Pharmaceuticals Law lawsuit legal market marijuana legalization Marijuana News News & Events Politics products science THC THC News thca , at January 5, 2021

Cannabis firm Canopy Growth sues GW Pharma, claiming patent infringement

Canadian cannabis producer Canopy Growth Corp. is suing Britain’s GW Pharmaceuticals in U.S. federal court, alleging that GW is knowingly…

By hempcbdtimes , in Canadian Medical Marijuana & Cannabis Industry News Cannabis Industry & Marijuana Business Briefs cannabis lawsuit Canopy Growth CBD CO2 extraction Epidiolex Europe Cannabis Industry & Marijuana Business News GW Pharma GW Pharmaceuticals Intellectual Property International Marijuana Business News marijuana intellectual property Marijuana Legalization and Regulatory News for Cannabis Businesses Medical Cannabis Industry & Recreational Marijuana Business News U.S. District Court United States Cannabis Industry & Marijuana Business News , at December 23, 2020

GW Pharmaceuticals cannabis drug gets regulatory OK in Australia

GW Pharmaceuticals’ plant-derived CBD drug Epidyolex received approval from Australia’s Therapeutic Goods Administration (TGA) to be used in treating seizures…

By hempcbdtimes , in Asia & Oceania Cannabis Industry & Marijuana Business News Australia Cannabis Industry & Marijuana Business Briefs Epidiolex Epidyolex GW Pharmaceuticals International Marijuana Business News Medical Cannabis Industry & Recreational Marijuana Business News , at September 24, 2020

Epidiolex maker GW Pharma turns in flat second quarter on pandemic impact

United Kingdom-based GW Pharmaceuticals posted marginal revenue growth in the second quarter over the previous quarter, citing challenges stemming from…

By hempcbdtimes , in Cannabis Industry & Marijuana Business Briefs Coronavirus Epidiolex Europe Cannabis Industry & Marijuana Business News GW Pharmaceuticals International Marijuana Business News Marijuana Stocks & Publicly Traded Cannabis Companies United Kingdom United States Cannabis Industry & Marijuana Business News , at August 10, 2020

Next Page »